Oxygenta Pharmaceutical Share Price

Small Cap | Pharmaceuticals and health care | BSE: 524636

₹77.43 image-1.58 (-2.00 %)

Last Updated: 13 Mar 2025 12:00 AM

Technicalsimage BEARISHimage

Overview

Open (₹) 78.62

High (₹) 78.62

Low (₹) 77.43

Prev. Close (₹) 79.01

Volume 3,701

VWAP (₹) 74.97

ROCE (%) -41.74

Industry P/E 43.95

TTM P/E -1935.75

P/B Ratio -12.88

Market Cap (₹) Cr.286.36

Dividend Yield (%)--

EPS (₹) -1.04

ROE17.30%

Sales Growth (%) 27.93

Profit Growth (%)-69.93

Day Range

78.6278.62

L
H

52 Week Range

27.62108.64

L
H

Historical Returns

Returns (6M)

37.65 %

Returns (1Y)

167.83 %

Returns (3Y)

244.13 %

Returns (5Y)

709.09 %

Returns (6M)

37.65 %

Returns (1Y)

167.83 %

Returns (3Y)

244.13 %

Returns (5Y)

709.09 %

SWOT Analysis

  • Growth in Net Profit Margin (QoQ)
  • Increasing Revenue every Quarter for the past 4 Quarters
  • Strong long-term momentum: Price above long-term moving averages (EMA_200)
  • Price above the pivot point indicates bullish sentiment.

Technicals
info_icon

Technical Rating

Trendimage  BEARISH
Moving Averages
Technical Indicators
Bullish
Bullish

RSI 47.62

MFI 17.15

ATR 2.74

Commodity Channel Index -123.59

ROC125 96.13

ROC21 -1.37

Williams %R -100.00

Resistance & Support
info_icon

TypeResistance 1 Resistance 2 Resistance 3 PP Support 1 Support 2 Support 3
Current74.9875.0375.0674.9574.9074.8774.82
Week Ago81.0181.1881.2680.9380.7680.6880.51
Month Ago78.9781.5884.5176.0473.4370.5067.89

EMA & SMA
info_icon

77.43

Current Price

EMA & SMApin

Bullish Moving Averages

2

Bearish Moving Averages

18

5 Day 78.88


9 Day 80.82


10 Day 81.54


12 Day 83.86


14 Day 84.50

20 Day 82.82


26 Day 81.81


50 Day 83.46


100 Day 85.73


200 Day 62.01

Deals & Announcements

Bulk and Block Deals

No bulk or block deals available.

Insider Trading

DateNameActionAvg. PriceQuantityDeal Value
13 Dec, 2024Raghavender Rao Kanuganti RevisedDisposal₹15.008,00,000BSE
13 Dec, 2024M V S Prasad Reddy RevisedAcquisition₹15.008,00,000BSE
13 Dec, 2024M V S Prasad Reddy RevisedAcquisition₹15.0069,52,600BSE
04 Oct, 2024Raghavender Rao KanugantiDisposal₹0.008,00,000BSE
03 Oct, 2024M V S Prasad ReddyAcquisition₹0.008,00,000BSE
30 Sept, 2024M V S Prasad ReddyAcquisition₹0.0069,52,600BSE
04 Sept, 2021Sai Sudhakar VankineniDisposal₹10.005,00,000BSE
04 Sept, 2021Snigdha VankineniAcquisition₹10.005,00,000BSE

Corporate Actions

No corporate actions available.

Announcements

DateSourceDetail
08 Mar, 2025BSE IndiaMark Corporate Advisors Pvt Ltd. (\Manager to the Offer\) has submitted to BSE a copy of Post Offer Advertisement under Regulation 18(12) of SEBI (SAST) Regulations, 2011, and amendments thereto (\SEBI (SAST) Regulations, 2011\) for the attention of the Public Shareholders of Oxygenta Pharmaceutical Ltd (\Target Company\).
14 Feb, 2025BSE IndiaUnaudited financial results for the Quarter ended December 31,2024.
14 Feb, 2025BSE IndiaUn Audited Financial results for the Quarter ended December 31,2024.
08 Feb, 2025BSE IndiaOxygenta Pharmaceutical Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2025 ,inter alia, to consider and approve This is to inform you that a meeting of Board of Directors of the company will be held on Friday, February 14, 2025, inter alia, to consider the Un-audited financial results of the Company for the Third quarter ended on December 31, 2024 pursuant to Regulation 33 of SEBI (LODR) Regulations, 2015.\r\nIn continuation to our earlier intimation of closure of trading window, we would like to inform that the trading window of the Company for all the designated persons and their immediate relatives will remain closed till February 16, 2025, which is 48 hours after the said Board Meeting. \r\nThis is for your information and records.
06 Feb, 2025BSE IndiaMark Corporate Advisors Pvt Ltd. (\Manager to the Offer\) has submitted to BSE a copy of Offer Opening Public Announcement under Regulation 18(7) of Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, as amended, for the attention of the eligible equity shareholders of Oxygenta Pharmaceutical Ltd (\the Company\).
04 Feb, 2025BSE IndiaIndependent Directors Committee (IDC) have submitted to BSE recommendations under Regulation 26(7) of SEBI (SAST) Regulations, 2011, for the Open Offer to Public Shareholders of Oxygenta Pharmaceutical Ltd.
31 Jan, 2025BSE IndiaMark Corporate Advisors Pvt Ltd. (\Manager to the Offer\) has submitted to BSE a copy of Letter of Offer for the attention of the eligible equity shareholders of Oxygenta Pharmaceutical Ltd (\the Company\).
17 Jan, 2025BSE IndiaThe Certificate issued by the RTA dated 03.01.2025 attached herewith
14 Nov, 2024BSE IndiaBoard of Directors approved the Un Audited Results for the Half year and Second quarter ended on September 30, 2024.
07 Nov, 2024BSE IndiaOxygenta Pharmaceutical Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2024 ,inter alia, to consider and approve This is to inform you that a meeting of Board of Directors of the company will be held on Thursday, November 14, 2024, inter alia, to consider the Un-audited financial results of the Company for the Second quarter ended on September 30, 2024 pursuant to Regulation 33 of SEBI (LODR) Regulations, 2015.\r\nIn continuation to our earlier intimation of closure of trading window, we would like to inform that the trading window of the Company for all the designated persons and their immediate relatives will remain closed till November 16, 2024, which is 48 hours after the said Board Meeting. \r\nThis is for your information and records.

Board Meetings

PurposeDetailsMeeting DateBroadcast Date
Quarterly Results--11 Feb, 202514 Feb, 2025
Quarterly Results--08 Nov, 202414 Nov, 2024
Quarterly Results--09 Aug, 202414 Aug, 2024
Audited Results--24 May, 202430 May, 2024
OthersInter-alia, to consider : 1. Raising of funds by way of issue of Equity Shares on preferential basis.04 Apr, 202408 Apr, 2024
Quarterly Results--07 Feb, 202414 Feb, 2024
Quarterly Results--07 Nov, 202314 Nov, 2023
Quarterly Results--09 Aug, 202314 Aug, 2023
Audited Results--25 May, 202330 May, 2023
Preferential issue of shares--24 Feb, 202327 Feb, 2023

Share Holding Pattern

Loading...

Loading...

Owner NameDec, 2024Sept, 2024Jun, 2024Mar, 2024Dec, 2023

About Oxygenta Pharmaceutical

Oxygenta Pharmaceutical is a Public Limited Listed company incorporated on 27/11/1990 and has its registered office in the State of Telangana, India. Company’s Corporate Identification Number(CIN) is L24110TG1990PLC012038 and registration number is 012038. Currently Company is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 39.64 Cr. and Equity Capital is Rs. 33.48 Cr. for the Year ended 31/03/2024. Read More

Parent Organisation

Not Applicable

Founded

1990

Managing Director

Dr. Sai Sudhakar Vankineni

NSE Symbol

--

Oxygenta Pharmaceutical Management

NameDesignation
Dr. Sai Sudhakar VankineniChairperson & Managing Director
Mr. Raghavender Rao KanugantiExecutive Director
Mr. Sunil Vishram ChawdaExecutive Director
Mrs. Sravani Reddy GantlaExecutive Director
Mr. Bharath Reddy GuntukuInd. Non-Executive Director
Mr. Vidya Sagar DevabhaktuniInd. Non-Executive Director
Mr. Sanagari Kondal ReddyInd. Non-Executive Director
Mrs. Padmaja SurapureddyInd. Non-Executive Director
Mrs. Aakanksha Sachin DubeyAddnl.Independent Director

Peer Comparison

StocksMarket CapMarket Price52 Week Low-High
Sun Pharmaceutical Industries₹4,03,916.05₹1,683.45 image
₹1,676.85(0.39%)
₹1,376.750 - ₹1,960.200
Divi's Laboratories₹1,49,205.29₹5,620.45 image
₹5,667.15(-0.82%)
₹3,350.050 - ₹6,448.750
Cipla₹1,18,065.23₹1,461.90 image
₹1,454.30(0.52%)
₹1,317.600 - ₹1,702.000
Torrent Pharmaceuticals₹1,03,430.62₹3,056.05 image
₹3,096.50(-1.31%)
₹2,488.000 - ₹3,589.950
Dr. Reddy's Laboratories₹92,453.48₹1,107.95 image
₹1,105.15(0.25%)
₹1,093.000 - ₹1,420.200

FAQs on Oxygenta Pharmaceutical

What is the share price of Oxygenta Pharmaceutical?

The share price of Oxygenta Pharmaceutical on 13 Mar, 2025 is ₹ 77.43.

What is 52W high and 52W low share price of Oxygenta Pharmaceutical?

The highest and lowest 52W share prices of Oxygenta Pharmaceutical are ₹ 108.640 and ₹ 27.620

What is the market cap of Oxygenta Pharmaceutical?

The market capitalization of Oxygenta Pharmaceutical as of 13 Mar, 2025 is ₹ 286.36 Crores

What is the P/E ratio of Oxygenta Pharmaceutical?

The current P/E ratio of Oxygenta Pharmaceutical as of 13 Mar, 2025 is 43.95

What is the PB ratio of Oxygenta Pharmaceutical?

The PB ratio of Oxygenta Pharmaceutical as of 13 Mar, 2025 is -12.88

Top Gainers

₹6.97image

₹5.81 (0.20%)

₹194.70image

₹162.25 (0.20%)

Top Losers

₹13.75image

₹135.15 (-0.90%)

₹9.60image

₹12.00 (-0.20%)

₹9.80image

₹93.55 (-0.90%)

₹0.99image

₹4.77 (-0.79%)

Market Indices

Sensex

₹73,828.91image

₹74,029.76 (0.00%)

Source : Dion Global Solutions Limited